ArticleCell death & disease2026
H3K9me2 is a determinant for the mitosis-to-meiosis transition in female germ cells.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The transition from mitosis to meiosis is crucial for determining the germ cell fate and ensuring the successive production of gametes. However, the mechanisms underlying meiotic entry within the dynamic chromatin context still remain poorly understood. Herein, we demonstrate that H3K9me2, a key marker of heterochromatin formation, plays a pivotal role in the transition from mitosis to meiosis in female germ cells of mice. We show that H3K9me2 maintains high levels in female germ cells from embryonic day 13.5 to 15.5, which closely corresponds to the timing of entry into meiosis in female mice. Interestingly, the reduction of H3K9me2 levels impairs the transition from pluripotency to meiosis in female germ cells, and the role of H3K9me2 appears to act upstream of Stra8 and Dazl. Mechanistically, the multi-omics sequencing analyses of sorted germ cells reveal that H3K9me2 is specifically enriched at the promoter region of pluripotency transcription factor SOX2 and components of the ATP-dependent chromatin remodeling complex. Reduction of H3K9me2 levels results in increased chromatin accessibility, specifically for the pluripotent factor and ATP-dependent chromatin remodelers, thereby impeding the complete exit from the pluripotency progression. Hence, our findings highlight the essential role of H3K9me2 in controlling the exit from the pluripotent state and coordinating the competency of female germ cells, thereby indicating the fundamental role of chromatin remodeling processes in mitosis-to-meiosis transition. This study will provide new insights into the role of chromatin remodeling in the process of gamete production from stem cell to germ cell in vitro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.